Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Serious Games

Date Submitted: Jan 5, 2022
Open Peer Review Period: Jan 5, 2022 - Mar 2, 2022
Date Accepted: Oct 11, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study

Orumaa M, Campbell S, Støer NC, Castle PE, Sen S, Tropé A, Adedimeji A, Nygård M

Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study

JMIR Serious Games 2022;10(4):e36197

DOI: 10.2196/36197

PMID: 36512401

PMCID: 9795393

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Impact of Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study

  • Madleen Orumaa; 
  • Suzanne Campbell; 
  • Nathalie C Støer; 
  • Philip E Castle; 
  • Sagar Sen; 
  • Ameli Tropé; 
  • Adebola Adedimeji; 
  • Mari Nygård

ABSTRACT

Background:

The availability of mobile phones has made the dissemination of health-related information easy and accessible. With gamification, mobile apps can nudge people to make informed health choices, including attending cervical cancer screening.

Objective:

This matched retrospective cohort study examined the association between exposure to the FightHPV mobile app gamified educational content and having a cervical exam in the following year.

Methods:

Women aged 20–69 years who signed an eConsent after downloading the FightHPV app in 2017 (intervention group) were 1:6 matched with women who have had the same age and the same screening history (reference group) in 2015. To estimate the FightHPV app impact, we estimated cumulative incidence and hazard ratios (HRs) with 95% confidence intervals (CI). We used data from the Norwegian Cervical Cancer Screening database and Statistics Norway.

Results:

For 658 women in the intervention group, we matched 3860 controls. 1-year after enrollment 44.2% (95% CI 30.3–47.9%) in the intervention group and 27.0% (95% CI 25.6–28.4%) in the reference group underwent a cervical exam (p<0.01). 6 months after enrollment, women exposed to the FightHPV app were 2-times more likely to attend any type of cervical exam (adjusted HR 2.3, 95% CI 2.0–2.7) during which they were almost 13-times more likely to be diagnosed with high-grade lesions (adjusted HR 12.7, 95% CI 5.0–32.5) compared the women in the reference group.

Conclusions:

FightHPV app exposure significantly increased the number of cervical exams across the various analyses. For the first time, we demonstrated the effectiveness of gamification combined with mobile technology in cancer prevention by empowering women to make active health-related decisions. Gamification can significantly improve the understanding of complicated scientific concepts behind interventions and increase the acceptance of proposed cancer control measures.


 Citation

Please cite as:

Orumaa M, Campbell S, Støer NC, Castle PE, Sen S, Tropé A, Adedimeji A, Nygård M

Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study

JMIR Serious Games 2022;10(4):e36197

DOI: 10.2196/36197

PMID: 36512401

PMCID: 9795393

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.